Polymers for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is one of the most common diseases of the central nervous system in the middle-aged and elderly population. It is a neurodegenerative disorder, and its main clinical symptoms include the loss of established memories, a decline in learning capacity, and the buildup of β-amylo...
Saved in:
| Main Authors: | Yunfeng Zhu, Haibin Xu, Chaoyan Yu, Wenting Jiang, Xiaowen Hou, Mingyue Ma, Ji Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1512941/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tau‐targeting nanoparticles for treatment of Alzheimer's disease
by: Shreya Pawar, et al.
Published: (2025-04-01) -
Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives
by: Kaylin Shanahan, et al.
Published: (2025-07-01) -
Self-Assembled Protein–Polymer Nanoparticles via Photoinitiated Polymerization-Induced Self-Assembly for Targeted and Enhanced Drug Delivery in Cancer Therapy
by: Gayathri R. Ediriweera, et al.
Published: (2025-02-01) -
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
by: Young-Ju Jang, et al.
Published: (2025-02-01) -
Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer’s Disease
by: Lai G, et al.
Published: (2025-06-01)